Cartesian Therapeutics grants inducement stock options for 52,450 shares to new hires

Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc.

RNAC

0.00
  • Cartesian Therapeutics issued stock options covering 52,450 common shares to two new employees under its Amended and Restated 2018 Employment Inducement Incentive Award Plan.
  • Options carry an exercise price of $6.39, set at Nasdaq closing price on April 1, 2026.
  • Vesting starts with 25% on April 1, 2027, followed by monthly installments through April 1, 2030.
  • Options have a 10-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604020705PRIMZONEFULLFEED9683129) on April 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.